nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—kidney cancer	0.853	1	CbGaD
Amcinonide—Pustule—Erlotinib—kidney cancer	0.00899	0.146	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00706	0.131	CbGpPWpGaD
Amcinonide—NR3C1—urine—kidney cancer	0.00451	0.154	CbGeAlD
Amcinonide—Leukoderma—Pazopanib—kidney cancer	0.00376	0.0611	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.00371	0.0686	CbGpPWpGaD
Amcinonide—Dermatitis acneiform—Everolimus—kidney cancer	0.00369	0.0601	CcSEcCtD
Amcinonide—Dermatitis acneiform—Erlotinib—kidney cancer	0.00356	0.058	CcSEcCtD
Amcinonide—ANXA1—nephron tubule—kidney cancer	0.00349	0.119	CbGeAlD
Amcinonide—Hypertrichosis—Everolimus—kidney cancer	0.00332	0.054	CcSEcCtD
Amcinonide—ANXA1—renal system—kidney cancer	0.00317	0.108	CbGeAlD
Amcinonide—ANXA1—kidney—kidney cancer	0.00307	0.105	CbGeAlD
Amcinonide—ANXA1—cortex of kidney—kidney cancer	0.00299	0.102	CbGeAlD
Amcinonide—ANXA1—gonad—kidney cancer	0.00285	0.0971	CbGeAlD
Amcinonide—ANXA1—cardiac atrium—kidney cancer	0.00284	0.097	CbGeAlD
Amcinonide—Folliculitis—Temsirolimus—kidney cancer	0.0027	0.0439	CcSEcCtD
Amcinonide—Leukoderma—Sunitinib—kidney cancer	0.00248	0.0403	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—ROS1—kidney cancer	0.00236	0.0436	CbGpPWpGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.00213	0.0394	CbGpPWpGaD
Amcinonide—Rash pustular—Temsirolimus—kidney cancer	0.00212	0.0346	CcSEcCtD
Amcinonide—Folliculitis—Everolimus—kidney cancer	0.00201	0.0327	CcSEcCtD
Amcinonide—Folliculitis—Erlotinib—kidney cancer	0.00194	0.0315	CcSEcCtD
Amcinonide—Folliculitis—Sorafenib—kidney cancer	0.00174	0.0283	CcSEcCtD
Amcinonide—Folliculitis—Dactinomycin—kidney cancer	0.00159	0.0258	CcSEcCtD
Amcinonide—Rash pustular—Erlotinib—kidney cancer	0.00153	0.0248	CcSEcCtD
Amcinonide—Tenderness—Erlotinib—kidney cancer	0.00139	0.0227	CcSEcCtD
Amcinonide—Secondary infection—Doxorubicin—kidney cancer	0.00127	0.0207	CcSEcCtD
Amcinonide—NR3C1—nephron tubule—kidney cancer	0.00121	0.0414	CbGeAlD
Amcinonide—Folliculitis—Paclitaxel—kidney cancer	0.00113	0.0183	CcSEcCtD
Amcinonide—NR3C1—renal system—kidney cancer	0.0011	0.0376	CbGeAlD
Amcinonide—NR3C1—kidney—kidney cancer	0.00107	0.0364	CbGeAlD
Amcinonide—NR3C1—cortex of kidney—kidney cancer	0.00104	0.0354	CbGeAlD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.00101	0.0186	CbGpPWpGaD
Amcinonide—NR3C1—gonad—kidney cancer	0.000989	0.0337	CbGeAlD
Amcinonide—NR3C1—cardiac atrium—kidney cancer	0.000987	0.0337	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.00098	0.0181	CbGpPWpGaD
Amcinonide—Tenderness—Gemcitabine—kidney cancer	0.000968	0.0158	CcSEcCtD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.0009	0.0166	CbGpPWpGaD
Amcinonide—Leukoderma—Doxorubicin—kidney cancer	0.00088	0.0143	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.000859	0.0159	CbGpPWpGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.000817	0.0151	CbGpPWpGaD
Amcinonide—Tenderness—Paclitaxel—kidney cancer	0.000811	0.0132	CcSEcCtD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.000799	0.0148	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.000729	0.0135	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.000703	0.013	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000627	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000627	0.0116	CbGpPWpGaD
Amcinonide—Infection—Temsirolimus—kidney cancer	0.000601	0.00978	CcSEcCtD
Amcinonide—Folliculitis—Doxorubicin—kidney cancer	0.000595	0.00969	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000595	0.011	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGR1—kidney cancer	0.000587	0.0108	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—ITPR2—kidney cancer	0.000577	0.0107	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000574	0.0106	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.000573	0.0106	CbGpPWpGaD
Amcinonide—Infection—Pazopanib—kidney cancer	0.000566	0.00921	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000558	0.0103	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.000518	0.00957	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.000518	0.00957	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000517	0.00956	CbGpPWpGaD
Amcinonide—Pain—Temsirolimus—kidney cancer	0.000517	0.00842	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000516	0.00953	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.000515	0.00951	CbGpPWpGaD
Amcinonide—Pain—Pazopanib—kidney cancer	0.000487	0.00793	CcSEcCtD
Amcinonide—Rash pustular—Doxorubicin—kidney cancer	0.000469	0.00764	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—OR4C13—kidney cancer	0.000466	0.0086	CbGpPWpGaD
Amcinonide—Stinging—Doxorubicin—kidney cancer	0.000462	0.00752	CcSEcCtD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	0.000461	0.00851	CbGpPWpGaD
Amcinonide—Infection—Everolimus—kidney cancer	0.000447	0.00727	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	0.000443	0.00818	CbGpPWpGaD
Amcinonide—Dexamethasone—ANXA1—kidney cancer	0.000431	0.242	CrCbGaD
Amcinonide—Infection—Erlotinib—kidney cancer	0.000431	0.00702	CcSEcCtD
Amcinonide—Pruritus—Temsirolimus—kidney cancer	0.000428	0.00696	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000427	0.00788	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000427	0.00788	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000423	0.00781	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OR4C13—kidney cancer	0.000423	0.00781	CbGpPWpGaD
Amcinonide—Pruritus—Pazopanib—kidney cancer	0.000403	0.00656	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000399	0.00737	CbGpPWpGaD
Amcinonide—Infection—Sorafenib—kidney cancer	0.000388	0.00631	CcSEcCtD
Amcinonide—Pain—Vinblastine—kidney cancer	0.000386	0.00629	CcSEcCtD
Amcinonide—Pain—Everolimus—kidney cancer	0.000385	0.00626	CcSEcCtD
Amcinonide—Dermatitis—Temsirolimus—kidney cancer	0.000381	0.0062	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—EPAS1—kidney cancer	0.000378	0.00699	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HNF1A—kidney cancer	0.000378	0.00699	CbGpPWpGaD
Amcinonide—Infection—Sunitinib—kidney cancer	0.000373	0.00608	CcSEcCtD
Amcinonide—Pain—Erlotinib—kidney cancer	0.000371	0.00604	CcSEcCtD
Amcinonide—Dermatitis contact—Doxorubicin—kidney cancer	0.00037	0.00602	CcSEcCtD
Amcinonide—Dermatitis—Pazopanib—kidney cancer	0.000359	0.00584	CcSEcCtD
Amcinonide—Infection—Dactinomycin—kidney cancer	0.000353	0.00575	CcSEcCtD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000352	0.0065	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.00035	0.00647	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000347	0.00642	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000339	0.00627	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000334	0.00618	CbGpPWpGaD
Amcinonide—Pain—Sorafenib—kidney cancer	0.000334	0.00544	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	0.000327	0.00605	CbGpPWpGaD
Amcinonide—Pain—Sunitinib—kidney cancer	0.000321	0.00523	CcSEcCtD
Amcinonide—Pruritus—Everolimus—kidney cancer	0.000318	0.00518	CcSEcCtD
Amcinonide—Infection—Vincristine—kidney cancer	0.000316	0.00514	CcSEcCtD
Amcinonide—Pruritus—Erlotinib—kidney cancer	0.000307	0.005	CcSEcCtD
Amcinonide—Pain—Dactinomycin—kidney cancer	0.000304	0.00495	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	0.000301	0.00556	CbGpPWpGaD
Amcinonide—Infection—Gemcitabine—kidney cancer	0.000299	0.00488	CcSEcCtD
Amcinonide—Dermatitis—Everolimus—kidney cancer	0.000283	0.00461	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	0.000282	0.0052	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000278	0.00513	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	0.000277	0.00512	CbGpPWpGaD
Amcinonide—Pruritus—Sorafenib—kidney cancer	0.000276	0.0045	CcSEcCtD
Amcinonide—Dermatitis—Erlotinib—kidney cancer	0.000273	0.00445	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—kidney cancer	0.000273	0.00504	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000272	0.00502	CbGpPWpGaD
Amcinonide—Pain—Vincristine—kidney cancer	0.000272	0.00442	CcSEcCtD
Amcinonide—Pruritus—Sunitinib—kidney cancer	0.000266	0.00433	CcSEcCtD
Amcinonide—Triamcinolone—BCHE—kidney cancer	0.000264	0.148	CrCbGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	0.000264	0.00487	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CDKN1B—kidney cancer	0.000259	0.00478	CbGpPWpGaD
Amcinonide—Pain—Gemcitabine—kidney cancer	0.000258	0.0042	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—IL2—kidney cancer	0.000253	0.00468	CbGpPWpGaD
Amcinonide—Infection—Paclitaxel—kidney cancer	0.000251	0.00408	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—OR4C13—kidney cancer	0.00025	0.00462	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	0.000248	0.00458	CbGpPWpGaD
Amcinonide—Clobetasol propionate—CYP1A1—kidney cancer	0.000248	0.139	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCND1—kidney cancer	0.000247	0.00456	CbGpPWpGaD
Amcinonide—Dermatitis—Sorafenib—kidney cancer	0.000246	0.004	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000245	0.00452	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—HIF1A—kidney cancer	0.000238	0.00439	CbGpPWpGaD
Amcinonide—Dermatitis—Sunitinib—kidney cancer	0.000237	0.00385	CcSEcCtD
Amcinonide—ANXA1—Peptide ligand-binding receptors—POMC—kidney cancer	0.000234	0.00432	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000233	0.00431	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000226	0.00418	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000218	0.00403	CbGpPWpGaD
Amcinonide—Pain—Paclitaxel—kidney cancer	0.000216	0.00351	CcSEcCtD
Amcinonide—Pruritus—Gemcitabine—kidney cancer	0.000213	0.00347	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—LATS1—kidney cancer	0.000212	0.00392	CbGpPWpGaD
Amcinonide—Infection—Capecitabine—kidney cancer	0.000206	0.00335	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK3—kidney cancer	0.000203	0.00376	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000203	0.00374	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000202	0.00373	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000201	0.00371	CbGpPWpGaD
Amcinonide—Dermatitis—Vincristine—kidney cancer	0.0002	0.00326	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—kidney cancer	0.000198	0.00366	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—POMC—kidney cancer	0.000197	0.00364	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	0.000196	0.00362	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000196	0.00362	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000196	0.00361	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK1—kidney cancer	0.000194	0.00358	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKAP13—kidney cancer	0.000193	0.00357	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000192	0.00355	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.00019	0.00351	CbGpPWpGaD
Amcinonide—Dermatitis—Gemcitabine—kidney cancer	0.00019	0.00309	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000186	0.00343	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AMER1—kidney cancer	0.000181	0.00334	CbGpPWpGaD
Amcinonide—Pruritus—Paclitaxel—kidney cancer	0.000179	0.00291	CcSEcCtD
Amcinonide—Pain—Capecitabine—kidney cancer	0.000177	0.00288	CcSEcCtD
Amcinonide—NR3C1—Endoderm Differentiation—APC—kidney cancer	0.000177	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000177	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000176	0.00325	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKAP13—kidney cancer	0.000176	0.00324	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000175	0.00323	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000168	0.0031	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000167	0.00309	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000166	0.00307	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ITPR2—kidney cancer	0.000164	0.00304	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—kidney cancer	0.000163	0.003	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000162	0.003	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000162	0.00299	CbGpPWpGaD
Amcinonide—Dermatitis—Paclitaxel—kidney cancer	0.000159	0.00259	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000159	0.00294	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000157	0.0029	CbGpPWpGaD
Amcinonide—Fluticasone furoate—ABCB1—kidney cancer	0.000154	0.0863	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CER1—kidney cancer	0.000151	0.0028	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GPC3—kidney cancer	0.000151	0.0028	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.00015	0.00277	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ITPR2—kidney cancer	0.000149	0.00276	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000148	0.00274	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000148	0.00273	CbGpPWpGaD
Amcinonide—Pruritus—Capecitabine—kidney cancer	0.000147	0.00239	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000146	0.0027	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	0.000145	0.00267	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	0.00014	0.00259	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000138	0.00256	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000135	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000133	0.00246	CbGpPWpGaD
Amcinonide—Infection—Doxorubicin—kidney cancer	0.000133	0.00216	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000132	0.00243	CbGpPWpGaD
Amcinonide—Dermatitis—Capecitabine—kidney cancer	0.00013	0.00212	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—SFRP2—kidney cancer	0.000129	0.00238	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000126	0.00233	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000124	0.0023	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	0.000124	0.00229	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—kidney cancer	0.000122	0.0682	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	0.000121	0.00224	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HARS—kidney cancer	0.000121	0.00224	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	0.00012	0.00222	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.00012	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—POMC—kidney cancer	0.000119	0.00221	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—kidney cancer	0.000119	0.00221	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	0.000119	0.0022	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	0.000118	0.00219	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	0.000118	0.00218	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	0.000117	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000116	0.00215	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	0.000114	0.00211	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000114	0.00211	CbGpPWpGaD
Amcinonide—Pain—Doxorubicin—kidney cancer	0.000114	0.00186	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000113	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000111	0.00204	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	0.000107	0.00198	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000105	0.00194	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	0.000104	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000104	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP2—kidney cancer	0.000104	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKAP13—kidney cancer	0.000104	0.00192	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF5B—kidney cancer	0.000103	0.00191	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000103	0.00191	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—kidney cancer	9.97e-05	0.0559	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	9.5e-05	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRB7—kidney cancer	9.49e-05	0.00175	CbGpPWpGaD
Amcinonide—Pruritus—Doxorubicin—kidney cancer	9.45e-05	0.00154	CcSEcCtD
Amcinonide—Prednisone—ABCB1—kidney cancer	9.38e-05	0.0526	CrCbGaD
Amcinonide—Dexamethasone—CYP1A1—kidney cancer	9.28e-05	0.052	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—ITPR2—kidney cancer	8.82e-05	0.00163	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—kidney cancer	8.65e-05	0.0485	CrCbGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	8.6e-05	0.00159	CbGpPWpGaD
Amcinonide—Betamethasone—ABCB1—kidney cancer	8.47e-05	0.0475	CrCbGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	8.45e-05	0.00156	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—kidney cancer	8.41e-05	0.00137	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	8.19e-05	0.00151	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNA1—kidney cancer	8e-05	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HSPB1—kidney cancer	7.95e-05	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EIF4EBP1—kidney cancer	7.95e-05	0.00147	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	7.8e-05	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PSMD7—kidney cancer	7.39e-05	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC1—kidney cancer	7.39e-05	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FLT1—kidney cancer	7.16e-05	0.00132	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—kidney cancer	7.15e-05	0.00132	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	6.87e-05	0.00127	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—POMC—kidney cancer	6.75e-05	0.00125	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	6.7e-05	0.00124	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EEF2—kidney cancer	6.65e-05	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PAK1—kidney cancer	6.64e-05	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUNB—kidney cancer	6.64e-05	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TET2—kidney cancer	6.38e-05	0.00118	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	6.22e-05	0.00115	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	6.18e-05	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—POMC—kidney cancer	6.13e-05	0.00113	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TCEB1—kidney cancer	5.83e-05	0.00108	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TCEB2—kidney cancer	5.83e-05	0.00108	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—kidney cancer	5.8e-05	0.0325	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	5.45e-05	0.00101	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	5.44e-05	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—kidney cancer	5.43e-05	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN2B—kidney cancer	5.4e-05	0.000998	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—kidney cancer	5.25e-05	0.000969	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RAF1—kidney cancer	5.05e-05	0.000934	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—kidney cancer	4.99e-05	0.000922	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—kidney cancer	4.93e-05	0.0276	CrCbGaD
Amcinonide—NR3C1—Gene Expression—RPL14—kidney cancer	4.74e-05	0.000876	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—kidney cancer	4.53e-05	0.000837	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—kidney cancer	4.32e-05	0.000798	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC2—kidney cancer	4.31e-05	0.000796	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—kidney cancer	4.13e-05	0.000763	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	3.86e-05	0.000714	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPB1—kidney cancer	3.86e-05	0.000714	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KIT—kidney cancer	3.8e-05	0.000703	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—kidney cancer	3.8e-05	0.000703	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK3—kidney cancer	3.64e-05	0.000673	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—POMC—kidney cancer	3.62e-05	0.000669	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PSMD7—kidney cancer	3.59e-05	0.000664	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BRAF—kidney cancer	3.58e-05	0.000661	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK1—kidney cancer	3.47e-05	0.00064	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—kidney cancer	3.31e-05	0.000612	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—kidney cancer	3.27e-05	0.000605	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—JUNB—kidney cancer	3.23e-05	0.000596	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—kidney cancer	3.01e-05	0.000556	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAF1—kidney cancer	2.99e-05	0.000552	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RELA—kidney cancer	2.97e-05	0.000549	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—kidney cancer	2.95e-05	0.000546	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTOR—kidney cancer	2.92e-05	0.000539	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—kidney cancer	2.74e-05	0.000505	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—kidney cancer	2.68e-05	0.000495	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CDKN2B—kidney cancer	2.63e-05	0.000485	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—kidney cancer	2.61e-05	0.000482	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—kidney cancer	2.6e-05	0.000481	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—kidney cancer	2.58e-05	0.000477	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—kidney cancer	2.52e-05	0.000465	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—kidney cancer	2.28e-05	0.00042	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK3—kidney cancer	2.15e-05	0.000398	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	2.11e-05	0.00039	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—kidney cancer	2.09e-05	0.000387	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK1—kidney cancer	2.05e-05	0.000378	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—kidney cancer	1.93e-05	0.000357	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—kidney cancer	1.78e-05	0.000328	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—kidney cancer	1.72e-05	0.000318	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MAPK3—kidney cancer	1.05e-05	0.000193	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—kidney cancer	1.02e-05	0.000188	CbGpPWpGaD
